What is a stop order? Stop orders come in three main

New Post Public Reply Private Reply Replies (0) Message Board
dw
272
What is a stop order?
Stop orders come in three main varieties: standard stop orders, stop-limit orders and trailing-stop orders. Stop and stop-limit orders are entered and held in the marketplace, while trailing-stop orders are held on a Schwab server until the conditions you define are met or exceeded, and then routed as market orders for possible execution.

To better understand how stop orders work, it's helpful to think of the stop price as a trigger. For example, once an execution occurs at your designated trigger price, your stop order becomes a market order to buy or sell that stock at the prevailing market price. Note that stop orders are inactive and hidden to the other market participants until the trigger price is reached.
Three types of stop orders
Stop order
Offers execution protection only, not price
No costs if not executed
Tends to work well in slowly declining markets
Generally does not work well in halted or gapping markets
Must be manually canceled and re-entered
Held on the book at the execution venue
Stop-limit order
Offers price protection only, not execution
No costs if not executed
Tends to work well in slowly declining markets
Generally does not work well in halted or gapping markets
Must be manually canceled and re-entered
Held on the book at the execution venue
Trailing-stop order
Offers execution protection only, not price
No costs if not executed
Tends to work well in slowly declining markets
Generally does not work well in halted or gapping markets
Automatically adjusts when underlying security increases in price
Held on Schwab servers
Source: Schwab Center for Financial Research

Stop orders (also known as stop-loss orders) and stop-limit orders are very similar, the primary difference being what happens once the stop price is triggered. A standard sell-stop order is triggered when an execution occurs at or below the stop price. When this occurs, a market order to sell is sent to the marketplace and your position will be closed out at the next available price.
Example: If the current price of a stock is $90 and you want to protect against a significant decline, you could enter a sell-stop order at $85. If an execution occurs at $85 or lower (at the same venue where your order resides), your stop order is triggered and a market order is entered to sell at the next available market price. Because the stop order is now a market order, all characteristics of market orders apply.

In most cases, your stock will be sold at a price that is close to the market price at the time the stop order is triggered. However, you must remember that a stop order becomes a market order, so in cases where the stock is dropping rapidly, the stock is halted and reopens for trading or when the stock gaps down in the morning (lower than the prior day's closing price), your execution price could be significantly lower than your stop price.
Stop-limit orders are most often used to sell a security at a specified limit price once the security has traded at or through a specified stop price. Therefore, it has two components: the stop price and the limit price, which may or may not be the same.

Unlike standard stop orders, with a stop-limit order, you must enter both a stop price and a limit price. In most cases, the limit price on a sell stop-limit order will be equal to or below the stop price. As the stock begins to decline in value, if the stock trades at or below the stop price, the order will trigger and become a limit order to sell at the specified limit price.

Because the order is now a limit order, execution cannot occur unless the position can be sold at the limit price specified (or better). If the next available price after the stop price is reached is below your limit price, your order will not be executed unless the price increases back up to your limit price. All other characteristics of limit orders apply as well.

To increase your chances of execution on a stop-limit order to sell, consider placing your limit price below your stop price. The farther below the stop price you place your limit price, the better chance you have of executing your order in a rapidly declining market.

With any type of limit order, including stop-limit orders, you aren't guaranteed execution because the stock may trade below the limit price before the order can be filled. This often occurs when a stock is reopened for trading after being halted due to a significant news announcement, or when the stock opens for trading in the morning at a price that is much lower than the previous day's closing price. When this occurs, a stop-limit order may trigger and be entered in the marketplace as a limit order, but the limit price may not be reached.
Example: The current price of a stock is $90. You place a stop-limit order to sell 100 shares with a stop price of $87.50 and a limit price of $87.50. If an execution occurs at $87.50 or below, your order will be triggered and become a limit order to sell at $87.50 or higher. If the market is falling fast, your order may not be filled at all if the next trade occurred at $87.45 and the stock continued to decline. However, if you entered your order with a stop price of $87.50 and a limit price of $87 and the next trade after the $87.50 trigger was at any price above $87, your order would typically be executed.

Keep in mind, your order can't be executed at a price that is inferior to the best available price, even if your limit allows for it. Therefore, in a slowly declining market, your order might be filled at $87.50 or better if market conditions allow for it.
With a trailing-stop order, the stop price trails the bid price of the stock as it moves higher. The stop price essentially self-adjusts and remains below the market price by the number of points or the percentage that you specify, as long as the stock is moving higher. Once the stock begins to move lower, the stop price freezes at the highest level it reaches.

In other words, the stop price can move higher indefinitely, but it can never move lower. If the stock falls enough to reach the stop price, the order is triggered and sent to the marketplace. The primary benefit of a trailing-stop order versus a regular stop order is that it doesn't have to be canceled and re-entered as the price of the stock increases. As mentioned above, this order is held on a Schwab server until the stop price (trigger) is reached.
Example: Assume you placed a 5% trailing-stop order on a recently purchased stock position. As the stock increases in price, if at any point the bid retraces (falls) by 5%, a market order will automatically be entered for the quantity you specified. For example, if you entered this order when the stock price was $100 per share, if the bid price increases 9% to $109 (assuming it never pulled back 5% on its way up to $109) and then drops 5% to $103.55, the order will be sent. The effective change from the time the trailing-stop was placed until the order was triggered would be 3.55% above where you originally placed the order. Since a trailing-stop order becomes a market order when triggered, it behaves very similar to a standard stop order.
Trailing-stop order

Source: StreetSmart Edge®
Where should you set your stop order?
When you place a stop, stop-limit or trailing-stop order, you have to decide how many points or what percentage below the stock price to place the order.

Many traders have a standard policy that they use, such as 5% or 10% below. For traders who determine the size of each trade based on the dollar amount invested, rather than the share quantity, a point value may be more effective than a percentage.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EICMA 2026: Groundbreaking Moves in Two-Wheel World

Updated Category News Views 27

Revving Up in Milan: A Record-Breaking EICMA If you're into two-wheelers as much as stocks, EICMA 2026 is where all the action is happening. They opened the door with a bang at Fiera Milano Rho, pulling off their biggest showcase yet. Ten halls packed to the brim, up from nine the previous year, creating buzz across the globe. Showcasing 765 exhibitors and 2,142 brands...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 0

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 178

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Telespazio & Rivada Forge Secure Satellite Network

Updated Category News Views 61

Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 164

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 234

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 226

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 172

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 157

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Biond's BND-67 Trial: New Hope Against Tumors

Updated Category News Views 0

Turning Heads with a New Approach in Immunotherapy Right off the bat, let's say something's brewing in the world of cancer treatment, and it's got a promising name: BND-67. We're talking about Biond Biologics, an ambitious Israeli outfit aiming to rewrite the rules with their new kid on the block in immunotherapies. This isn't about business as usual. It's about a fresh...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding America's Growing Net Debtor Status: Implications Ahead

Updated Category News Views 181

Shifting Dynamics of America's Net Debtor Status By Jamie McGeever Foreign investment in the U.S. has consistently outnumbered American investments abroad for several decades. This persistent imbalance has raised concerns among analysts about potential repercussions for the dollar's confidence. Despite these warnings, the anticipated crisis regarding this dynamic has not...

Continue Reading
Understanding Doximity's Short Interest Trends and Insights

Updated Category News Views 115

Diving Deeper into Doximity's Short Interest Analysis Doximity (DOCS) has attracted attention in recent financial discussions due to its short interest metrics. Recently, it was reported that the short percent of float for Doximity has decreased by 4.22%. This decline translates to approximately 5.64 million shares sold short, constituting about 4.54% of the company’s...

Continue Reading
Explore the Future of Biologics at Apogee's R&D Day

Updated Category News Views 100

Join Apogee Therapeutics' First Virtual R&D Day Apogee Therapeutics, Inc., a promising clinical-stage biotechnology firm, is poised to present its inaugural virtual Research and Development Day. Scheduled for 10:00 a.m. ET on a soon-to-come date, this event invites those interested in the transformative work happening in the field of biotechnology. Unveiling Innovations...

Continue Reading
Empowering Education: Oklahoma City School Choice Showcase

Updated Category News Views 122

Oklahoma City School Choice Showcase Set to Inspire Families Students from around Oklahoma City are gearing up for a fantastic event at Dove Science Academy, with a heartfelt message highlighting their love for their schools. The exciting gathering will showcase K–12 school choice options available in the state, aligning perfectly with the celebratory spirit of National...

Continue Reading
Experian Uncovers Identity Fraud Trends in 2024 Global Report

Updated Category News Views 661

Comprehensive Insights from the 2024 Global Identity & Fraud Report Experian has unveiled its 2024 Global Identity & Fraud Report, delivering an in-depth analysis of consumer and business responses to prevailing fraud patterns as well as effective mitigation strategies within the financial services sector. This extensive report is backed by data accumulated from over...

Continue Reading